World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management

@article{Gotlib2015WorldHO,
  title={World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management},
  author={Jason Gotlib},
  journal={American Journal of Hematology},
  year={2015},
  volume={90}
}
  • J. Gotlib
  • Published 1 November 2015
  • Medicine
  • American Journal of Hematology
Disease overview: The eosinophilias encompass a broad range of non‐hematologic (secondary or reactive) and hematologic (primary, clonal) disorders with potential for end‐organ damage. 

IgG4‐related disease and lymphocyte‐variant hypereosinophilic syndrome: A comparative case series

To compare the clinical and laboratory features of IgG4‐related disease (IgG4‐RD) and lymphocyte‐variant hypereosinophilic syndrome (L‐HES), two rare diseases that often present with lymphadenopathy,

HOW I DIAGNOSE HYPEREOSINOPHILIC SYNDROMES *

An overview of the term "Hypereosinophilic syndromes" is given and aetiology and the approach to diagnosis are discussed.

The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes

Fusion genes derived from the platelet-derived growth factor receptor beta (PDGFRB) or alpha (PDGFRA) play an important role in the pathogenesis of eosinophilia-associated myeloproliferative neopla...

Eosinophilic Diseases : A Spotlight

The pace of clinical research and emergence of novel targeted therapies for EADs is accelerating; however, progress remains hindered by knowledge gaps in the eosinophil biology and pathophysiology of Eads.

A 68-year old woman with asymptomatic hypereosinophilia.

This work presents the case of a 68-year-old woman with isolated asymptomatic hypereosinophilia, a group of heterogeneous disorders with persistent eos inophilia and organ involvement.

NON-CLASSIC MYELOPROLIFERATIVE NEOPLASMS : ARE WE REALLY AWARE OF THESE RARE DISEASES IN DAILY PRACTICE ? *

Molecular genetic testing should take part in the diagnostic work-up of suspected patients with rare MPN, the least frequent type, when an MPN has definite MPN features but does not meet diagnostic criteria for either the classic or the other non-classic MPN.

Myeloid/Lymphoid neoplasms with abnormalities of PDGFRA

This insert represents a review of myeloid and lymphoid neoplasms with abnormalities of PDGFRA including clinical presentation, morphologic review, and cytogenetic findings.

Updates for the treatment of EGPA.

Hypereosinophilic Syndrome After Liver Transplantation: A Case Report and a Review of the Literature

A 12-year-old boy who developed severe hypereosinophilia 11 years after liver transplantation due to biliary atresia was reported, and treatment with prednisolone resulted in an immediate response with rapid reduction of eos inophils, normalization of liver enzymes, and amelioration of any clinical symptoms.

Fulminant course of a case of idiopathic hypereosinophilic syndrome

This short communication brings to your notice one such patient with idiopathic HES who had a progressive fulminant fatal course.
...

References

SHOWING 1-10 OF 175 REFERENCES

Evaluation of the prognostic significance of Eosinophilia and Basophilia in a larger cohort of patients with myelodysplastic syndromes

Little is known about the impact of eosinophils and basophils in patients with myelodysplastic syndromes, but the prognostic value of neutropenia, thrombocytopenia and monocytosis have been documented.

THE HYPEREOSINOPHILIC SYNDROME: Analysis of Fourteen Cases With Review of The Literature

A group of 14 patients had hematologic, cardiac, and neurologic abnormalities attributable to this disease, and patient survival and response to chemotherapy was significantly better in this group than in previously reported patients.

Carbamazepine‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe drug reaction, most commonly to aromatic anticonvulsants with a delayed onset, variable clinical

Hypereosinophilic syndrome: successful allogeneic bone marrow transplantation.

A patient with well-documented hypereosinophilic syndrome who underwent successful allogeneic bone marrow transplantation (BMT) is reported. This therapeutic modality should be considered in patients

Hypereosinophilic syndrome: successful allogeneic bone marrow transplantation.

A patient with well-documented hypereosinophilic syndrome who underwent successful allogeneic bone marrow transplantation (BMT) is reported. This therapeutic modality should be considered in patients

Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations

Dr. Roufosse provides an updated classification of hypereosinophilic syndromes and discusses the recent advances in this field, including fascinating pathogenic mechanisms and novel targeted therapeutic approaches.

Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript

Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript

Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome

Long-term follow-up of FIP1L1-PDGFRA -mutated patients with eosinophilia: survival and clinical outcome

Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia

Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia

Response to vincristine treatment in a case of idiopathic hypereosinophilic syndrome with multiple clinical manifestations.

A case is reported of idiopathic hypereosinophilic syndrome involving many organs and systems and with a wide range of clinical findings: hematologic, cardiovascular, skin, pulmonary, spleen, liver,
...